Hemispherx Biopharma (HEB) Active After New $70M Equity Distribution Agreement
Tweet Send to a Friend
Hemispherx Biopharma (NYSE: HEB) active after disclosing:On July 17, 2019, Hemispherx Biopharma, Inc. and Maxim Group LLC terminated their prior ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
